BERNS PAUL L

Chief Executive Officer at ALLOS THERAPEUTICS INC · on record since Mar 13, 2006
Director at Neumora Therapeutics, Inc. · on record since Sep 14, 2023
Director at XENOPORT INC · on record since May 4, 2006
Director at Metsera, Inc. · on record since Jan 30, 2025
10% owner at Metsera, Inc. · on record since Jan 30, 2025
See Remarks at Neumora Therapeutics, Inc. · on record since Feb 20, 2025
10% owner at Lyell Immunopharma, Inc. · on record since Jul 29, 2025
Director at Kardigan, Inc. · on record since Jun 18, 2026
10% owner at Kardigan, Inc. · on record since Jun 18, 2026
Director at BONE CARE INTERNATIONAL INC · on record since Jul 25, 2003
Director at Jazz Pharmaceuticals plc · on record since Jun 8, 2010
President/CEO at BONE CARE INTERNATIONAL INC · on record since Jun 24, 2004
Director at Anacor Pharmaceuticals, Inc. · on record since Jun 1, 2012
President and CEO at Anacor Pharmaceuticals, Inc. · on record since Mar 25, 2014
Director at Cellectar Biosciences, Inc. · on record since Aug 18, 2014
Director at Yarrow Bioscience, Inc. · on record since Jan 24, 2018
Director at Unity Biotechnology, Inc. · on record since May 7, 2018
Director at EQRx, Inc. · on record since Dec 21, 2021

Insider trading activity of BERNS PAUL L

Transactions on record: 272; since Jun 25, 2004

Open-market buys: 7; $47M

Open-market sells: 77; $25M

Companies traded: 13; last filing Aug 21, 2026

Figures computed from official regulatory filings — .

Companies where BERNS PAUL L has traded

24 tx · $57.9K · Aug 21, 2026
6 tx · $20M · Jun 24, 2026
1 tx · $12.5M · Mar 9, 2026
12 tx · $14.2M · Nov 13, 2025
8 tx · Jun 21, 2024
7 tx · Nov 9, 2023
54 tx · $5.4M · Aug 9, 2021
2 tx · Aug 8, 2019
55 tx · $47.3M · Jun 24, 2016
34 tx · $866.6K · May 19, 2016
4 tx · $250K · Apr 21, 2016
47 tx · $15.1M · Sep 5, 2012
18 tx · $16M · Jul 1, 2005

Track record of BERNS PAUL L

Statistical track record

Free account

Open-market buys: 8

Last buy: Jun 22, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BERNS PAUL L

Co-insiders of BERNS PAUL L

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Neumora Therapeutics, Inc.Listing on record	Aug 21, 2026	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kardigan, Inc.Listing unverified	Jun 24, 2026	Buy	1,250,000	16.00 USD	$20M	conv 54ClusterUnusual size	SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	Other	13,792,035	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	Award	20,706	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-2,306,401	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-5,148,587	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-1,204,000	—	n/a (No price was disclosed in the filing)		SEC
Lyell Immunopharma, Inc.Listing on record	Mar 9, 2026	Buy	488,090	25.61 USD	$12.5M	conv 61First in 12mo	SEC
Neumora Therapeutics, Inc.Listing on record	Feb 19, 2026	Sell	-9,819	3.51 USD	$34.5K		SEC
Neumora Therapeutics, Inc.Listing on record	Jan 9, 2026	AwardD (derivative)	1,650,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	AwardD (derivative)	4,031	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-957,559	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-4,031	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-7,523,682	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-8,313,680	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	OtherD (derivative)	-24,188	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	OtherD (derivative)	-223,430	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	342,500	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-342,500	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-955,864	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	497,049	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	955,864	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-497,049	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Neumora Therapeutics, Inc.Listing on record	Aug 21, 2026	AwardD (derivative)	500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kardigan, Inc.Listing unverified	Jun 24, 2026	Buy	1,250,000	16.00 USD	$20M	conv 54ClusterUnusual size	SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	Other	13,792,035	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	Award	20,706	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-2,306,401	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-5,148,587	—	n/a (No price was disclosed in the filing)		SEC
Kardigan, Inc.Listing unverified	Jun 22, 2026	OtherD (derivative)	-1,204,000	—	n/a (No price was disclosed in the filing)		SEC
Lyell Immunopharma, Inc.Listing on record	Mar 9, 2026	Buy	488,090	25.61 USD	$12.5M	conv 61First in 12mo	SEC
Neumora Therapeutics, Inc.Listing on record	Feb 19, 2026	Sell	-9,819	3.51 USD	$34.5K		SEC
Neumora Therapeutics, Inc.Listing on record	Jan 9, 2026	AwardD (derivative)	1,650,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	AwardD (derivative)	4,031	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-957,559	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-4,031	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-7,523,682	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	Other	-8,313,680	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	OtherD (derivative)	-24,188	—	n/a (No price was disclosed in the filing)		SEC
Metsera, Inc.Listing unverified	Nov 13, 2025	OtherD (derivative)	-223,430	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	342,500	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-342,500	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-955,864	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	497,049	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	955,864	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-497,049	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	AwardD (derivative)	2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Neumora Therapeutics, Inc.Listing on record	May 30, 2025	OtherD (derivative)	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC